通过与HSpa5相互作用,RhoA加速动脉样硬化的进展.
Ruoyu Dong1, Can Cao2, Jikuan Li1
1Department of Vascular Surgery, Hebei General Hospital, No.348, Heping West Road, Shijiazhuang, 050000, Hebei, China.
Scientific reports
|January 6, 2026
概括
罗亚蛋白促进动脉样硬化 (AS) 通过增强血管光滑肌肉细胞迁移和线粒细胞衰变. 准RhoA及其与HSpa5的相互作用可能为AS治疗提供新的治疗策略.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 细胞生物学 细胞生物学
背景情况:
- 动脉样硬化 (AS) 是一种复杂的心血管疾病.
- 在AS中RhoA的精确调节机制尚不清楚.
研究的目的:
- 调查罗亚在AS进展中的作用和潜在机制.
- 在AS的背景下探索RhoA和HSpa5之间的相互作用.
主要方法:
- 建立了一个高脂肪饮食诱导的AS小鼠模型.
- 在体内利用腺相关病毒对RhoA进行操纵.
- 分析了氧化低密度脂蛋白 (ox-LDL) 处理的小鼠大动脉血管光滑肌细胞 (MOVAS),使用各种测定方法 (细胞计数套件-8,Transwell迁移,电子显微镜,西部涂抹).
- 通过生物信息分析,共免疫沉和免疫光检测研究了RhoA-Hspa5相互作用.
主要成果:
- 在AS小鼠中,RhoA显著上调,并在大动脉光滑肌层局部化.
- 在体外,RhoA抑制抑制了MOVAS细胞的活力,迁移,入侵和线粒细胞吸收,并在体内减少了AS斑块形成和炎症.
- 确定HSpa5与RhoA相互作用,其表达与RhoA水平正相关.
- Hspa5过度表达逆转了RhoA沉默对细胞行为和AS进展的抑制作用.
结论:
- 通过与HSpa5.5相互作用,RhoA通过增强血管光滑肌肉细胞迁移,入侵和线粒细胞吸收来促进AS.
- 罗亚在加剧AS进展方面发挥着关键作用.
- 罗亚是治疗动脉样硬化的潜在治疗点.
相关概念视频
01:30Atherosclerosis I: Introduction
890
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
890
01:26Atherosclerosis III: Management
312
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
312
01:26Coronary Artery Disease II: Pathophysiology
360
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
360
01:30Coronary Artery Disease I: Introduction
869
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
869
01:38Inflammation
61.6K
Overview
61.6K
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
455
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
455